These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis. Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448 [TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of nondermatophyte molds isolated from onycomycosis to antifungal drugs. Trovato L; Rapisarda MF; Greco AM; Galata F; Oliveri S J Chemother; 2009 Aug; 21(4):403-7. PubMed ID: 19622458 [TBL] [Abstract][Full Text] [Related]
4. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis. Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383 [TBL] [Abstract][Full Text] [Related]
5. Sertaconazole: in-vitro antifungal activity against vaginal and other superficial yeast isolates. Carrillo-Muñoz AJ; Brió S; Quindós G; Palacín C; Guglietta A; Espinel-Ingroff A J Chemother; 2001 Oct; 13(5):555-62. PubMed ID: 11760221 [TBL] [Abstract][Full Text] [Related]
6. In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates. Skóra M; Macura AB; Bulanda M Med Mycol; 2014 Oct; 52(7):723-7. PubMed ID: 25049036 [TBL] [Abstract][Full Text] [Related]
7. [Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?]. Carrillo-Muñoz AJ; Santos P; del Valle O; Casals JB; Quindós G Rev Esp Quimioter; 2004 Sep; 17(3):244-9. PubMed ID: 15619653 [TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility testing of Scopulariopsis brevicaulis strains using agar diffusion method. Skóra M; Macura AB Wiad Parazytol; 2011; 57(2):111-6. PubMed ID: 21682097 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945 [TBL] [Abstract][Full Text] [Related]
10. [Influence of the ecological group on the in vitro antifungal susceptibility of dermatophytic fungi]. Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G Rev Iberoam Micol; 2013; 30(2):130-3. PubMed ID: 23318162 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354 [TBL] [Abstract][Full Text] [Related]
12. Sertaconazole antifungal profile determined by a microdilution method versus nine topical substances against dermatophyte fungi. Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G Chemotherapy; 2012; 58(5):399-404. PubMed ID: 23296325 [TBL] [Abstract][Full Text] [Related]
13. Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs. Torres-Rodríguez JM; Madrenys-Brunet N; Siddat M; López-Jodra O; Jimenez T J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):25-31. PubMed ID: 9731962 [TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain. Zalacain A; Obrador C; Martinez JP; Viñas M; Vinuesa T Med Mycol; 2011 Jul; 49(5):495-9. PubMed ID: 21142899 [TBL] [Abstract][Full Text] [Related]
17. In vitro combination of antifungal agents against Malassezia pachydermatis. Schlemmer KB; de Jesus FPK; Loreto ES; Farias JB; Alves SH; Ferreiro L; Santurio JM Med Mycol; 2019 Apr; 57(3):324-327. PubMed ID: 29924372 [TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal susceptibility of clinical isolates of Arthrographis kalrae, a poorly known opportunistic fungus. Sandoval-Denis M; Giraldo A; Sutton DA; Fothergill AW; Guarro J Mycoses; 2014 Apr; 57(4):247-8. PubMed ID: 24147779 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats. Han HS; Kano R; Chen C; Noli C Vet Dermatol; 2017 Feb; 28(1):156-e32. PubMed ID: 28133872 [TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes. Santos DA; Hamdan JS Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]